ADP-ribosylation factor 6 modulates adrenergic stimulated lipolysis in adipocytes

American Journal of Physiology - Cell Physiology

Volumn 298, Issue 4, 2010, Pages

  Liu, Yingqiu ^a   Zhou, Dequan ^a   Abumrad, Nada A ^a   Su, Xiong ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

adrenergic receptor; Trafficking

Indexed keywords

8 BROMO CYCLIC AMP; ADENOSINE DIPHOSPHATE RIBOSYLATION FACTOR 6; BETA ADRENERGIC RECEPTOR; DYNAMIN; DYNASORE; FATTY ACID; FORSKOLIN; INSULIN; ISOBUTYLMETHYLXANTHINE; ISOPRENALINE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADIPOCYTE; ADIPOSE TISSUE; ADRENERGIC STIMULATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL LINE; CELL MEMBRANE; CONTROLLED STUDY; ENDOCYTOSIS; ENZYME INHIBITION; LIPID COMPOSITION; LIPOGENESIS; LIPOLYSIS; METABOLIC REGULATION; MOLECULAR MIMICRY; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN TRANSPORT; RECEPTOR DOWN REGULATION; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

1-METHYL-3-ISOBUTYLXANTHINE; 3T3-L1 CELLS; 8-BROMO CYCLIC ADENOSINE MONOPHOSPHATE; ADIPOCYTES; ADP-RIBOSYLATION FACTORS; ADRENERGIC BETA-AGONISTS; ANIMALS; ENDOCYTOSIS; FORSKOLIN; INSULIN; ISOPROTERENOL; LIPOLYSIS; MICE; MICE, OBESE; PHOSPHODIESTERASE INHIBITORS; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRIGLYCERIDES;

MURINAE; MUS;

EID: 77950230524     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00541.2009     Document Type: Article

References (57)

1. Abban CY, Bradbury NA, Meneses PI. HPV16 and BPV1 infection can be blocked by the dynamin inhibitor dynasore. Am J Ther 15: 304-311, 2008.
2. Bederman IR, Previs SF. Hormonal regulation of intracellular lipolysis in C57BL/6J mice: effect of diet-induced adiposity and data normalization. Metabolism 57: 1405-1413, 2008.
3. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37: 911-917, 1959.
4. Bollheimer LC, Skelly RH, Chester MW, McGarry JD, Rhodes CJ. Chronic exposure to free fatty acid reduces pancreatic beta cell insulin content by increasing basal insulin secretion that is not compensated for by a corresponding increase in proinsulin biosynthesis translation. J Clin Invest 101: 1094-1101, 1998.
5. Breit A, Lagace M, Bouvier M. Hetero-oligomerization between beta2- and beta3-adrenergic receptors generates a beta-adrenergic signaling unit with distinct functional properties. J Biol Chem 279: 28756-28765, 2004.
6. Carmen GY, Victor SM. Signalling mechanisms regulating lipolysis. Cell Signal 18: 401-408, 2006.
7. Carpene C, Rebourcet MC, Guichard C, Lafontan M, Lavau M. Increased alpha 2-adrenergic binding sites and antilipolytic effect in adipocytes from genetically obese rats. J Lipid Res 31: 811-819, 1990.
8. Chamberlain LH, Gould GW. The vesicle- and target-SNARE proteins that mediate Glut4 vesicle fusion are localized in detergent-insoluble lipid rafts present on distinct intracellular membranes. J Biol Chem 277: 49750-49754, 2002.
9. Collins S, Daniel KW, Rohlfs EM, Ramkumar V, Taylor IL, Gettys TW. Impaired expression and functional activity of the beta 3- and beta 1-adrenergic receptors in adipose tissue of congenitally obese (C57BL/6J ob/ob) mice. Mol Endocrinol 8: 518-527, 1994.
10. Donaldson JG. Multiple roles for Arf6: sorting, structuring, and signaling at the plasma membrane. J Biol Chem 278: 41573-41576, 2003.
11. Duncan RE, Ahmadian M, Jaworski K, Sarkadi-Nagy E, Sul HS. Regulation of lipolysis in adipocytes. Annu Rev Nutr 27: 79-101, 2007.
12. Ferguson SS. Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling. Pharmacol Rev 53: 1-24, 2001.
13. Finn PF, Dice JF. Proteolytic and lipolytic responses to starvation. Nutrition 22: 830-844, 2006.
14. Fruhbeck G, Aguado M, Gomez-Ambrosi J, Martinez JA. Lipolytic effect of in vivo leptin administration on adipocytes of lean and ob/ob mice, but not db/db mice. Biochem Biophys Res Commun 250: 99-102, 1998.
15. Gauthier MS, Miyoshi H, Souza SC, Cacicedo JM, Saha AK, Greenberg AS, Ruderman NB. AMP-activated protein kinase is activated as a consequence of lipolysis in the adipocyte: potential mechanism and physiological relevance. J Biol Chem 283: 16514-16524, 2008.
16. Granneman JG, Moore HP. Location, location: protein trafficking and lipolysis in adipocytes. Trends Endocrinol Metab 19: 3-9, 2008.
17. Greenberg AS, Shen WJ, Muliro K, Patel S, Souza SC, Roth RA, Kraemer FB. Stimulation of lipolysis and hormone-sensitive lipase via the extracellular signal-regulated kinase pathway. J Biol Chem 276: 45456-45461, 2001.
18. Guilherme A, Virbasius JV, Puri V, Czech MP. Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol 9: 367-377, 2008.
19. Hajri T, Hall AM, Jensen DR, Pietka TA, Drover VA, Tao H, Eckel R, Abumrad NA. CD36-facilitated fatty acid uptake inhibits leptin production and signaling in adipose tissue. Diabetes 56: 1872-1880, 2007.
20. Horowitz JF, Klein S. Lipid metabolism during endurance exercise. Am J Clin Nutr 72: 558S-563S, 2000.
21. Houndolo T, Boulay PL, Claing A. G protein-coupled receptor endocytosis in ADP-ribosylation factor 6-depleted cells. J Biol Chem 280: 5598-5604, 2005.
22. Hunzicker-Dunn M, Gurevich VV, Casanova JE, Mukherjee S. ARF6: a newly appreciated player in G protein-coupled receptor desensitization. FEBS Lett 521: 3-8, 2002.
23. Iyer V, Tran TM, Foster E, Dai W, Clark RB, Knoll BJ. Differential phosphorylation and dephosphorylation of beta2-adrenoceptor sites Ser262 and Ser355,356. Br J Pharmacol 147: 249-259, 2006.
24. Klein S, Peters EJ, Holland OB, Wolfe RR. Effect of short- and long-term β-adrenergic blockade on lipolysis during fasting in humans. Am J Physiol Endocrinol Metab 257: E65-E73, 1989.
25. Langin D. Control of fatty acid and glycerol release in adipose tissue lipolysis. CR Biol 329: 598-607, 2006.
26. Laporte SA, Oakley RH, Zhang J, Holt JA, Ferguson SS, Caron MG, Barak LS. The beta2-adrenergic receptor/betaarrestin complex recruits the clathrin adaptor AP-2 during endocytosis. Proc Natl Acad Sci USA 96: 3712-3717, 1999.
27. Lawrence J, Mundell SJ, Yun H, Kelly E, Venkateswarlu K. Centaurin-alpha 1, an ADP-ribosylation factor 6 GTPase activating protein, inhibits beta 2-adrenoceptor internalization. Mol Pharmacol 67: 1822-1828, 2005.
28. Lazar DF, Wiese RJ, Brady MJ, Mastick CC, Waters SB, Yamauchi K, Pessin JE, Cuatrecasas P, Saltiel AR. Mitogen-activated protein kinase kinase inhibition does not block the stimulation of glucose utilization by insulin. J Biol Chem 270: 20801-20807, 1995.
29. Lefkowitz RJ. G protein-coupled receptors. III. New roles for receptor kinases and beta-arrestins in receptor signaling and desensitization. J Biol Chem 273: 18677-18680, 1998.
30. Li J, Peters PJ, Bai M, Dai J, Bos E, Kirchhausen T, Kandror KV, Hsu VW. An ACAP1-containing clathrin coat complex for endocytic recycling. J Cell Biol 178: 453-464, 2007.
31. Liang W, Curran PK, Hoang Q, Moreland RT, Fishman PH. Differences in endosomal targeting of human (beta)1- and (beta)2-adrenergic receptors following clathrin-mediated endocytosis. J Cell Sci 117: 723-734, 2004.
32. Liggett SB, Freedman NJ, Schwinn DA, Lefkowitz RJ. Structural basis for receptor subtype-specific regulation revealed by a chimeric beta 3/beta 2-adrenergic receptor. Proc Natl Acad Sci USA 90: 3665-3669, 1993.
33. Lu W, Ma H, Sheng ZH, Mochida S. Dynamin and activity regulate synaptic vesicle recycling in sympathetic neurons. J Biol Chem 284: 1930-1937, 2009.
34. Macia E, Ehrlich M, Massol R, Boucrot E, Brunner C, Kirchhausen T. Dynasore, a cell-permeable inhibitor of dynamin. Dev Cell 10: 839-850, 2006.
35. Marchese A, Chen C, Kim YM, Benovic JL. The ins and outs of G protein-coupled receptor trafficking. Trends Biochem Sci 28: 369-376, 2003.
36. Martins IJ, Redgrave TG. Obesity and post-prandial lipid metabolism. Feast or famine? J Nutr Biochem 15: 130-141, 2004.
37. Morisco C, Marrone C, Galeotti J, Shao D, Vatner DE, Vatner SF, Sadoshima J. Endocytosis machinery is required for beta1-adrenergic receptor-induced hypertrophy in neonatal rat cardiac myocytes. Cardiovasc Res 78: 36-44, 2008.
38. Moule SK, Denton RM. The activation of p38 MAPK by the beta-adrenergic agonist isoproterenol in rat epididymal fat cells. FEBS Lett 439: 287-290, 1998.
39. Mukherjee S, Tessema M, and Wandinger-Ness A. Vesicular trafficking of tyrosine kinase receptors and associated proteins in the regulation of signaling and vascular function. Circ Res 98: 743-756, 2006.
40. Nakamura J. Protein kinase C attenuates beta-adrenergic receptor-mediated lipolysis, probably through inhibition of the beta1-adrenergic receptor system. Arch Biochem Biophys 447: 1-10, 2006.
41. Nilsson R, Ahmad F, Sward K, Andersson U, Weston M, Manganiello V, Degerman E. Plasma membrane cyclic nucleotide phosphodiesterase 3B (PDE3B) is associated with caveolae in primary adipocytes. Cell Signal 18: 1713-1721, 2006.
42. Parent A, Hamelin E, Germain P, Parent JL. Rab11 regulates the recycling of the beta2-adrenergic receptor through a direct interaction. Biochem J 418: 163-172, 2009.
43. Rybin VO, Xu X, Lisanti MP, Steinberg SF. Differential targeting of beta-adrenergic receptor subtypes and adenylyl cyclase to cardiomyocyte caveolae. A mechanism to functionally regulate the cAMP signaling pathway. J Biol Chem 275: 41447-41457, 2000.
44. Ryden M, Dicker A, van Harmelen V, Hauner H, Brunnberg M, Perbeck L, Lonnqvist F, Arner P. Mapping of early signaling events in tumor necrosis factor-alpha -mediated lipolysis in human fat cells. J Biol Chem 277: 1085-1091, 2002.
45. Scarselli M, Donaldson JG. Constitutive internalization of G protein-coupled receptors and G proteins via clathrin-independent endocytosis. J Biol Chem 284: 3577-3585, 2009.
46. Schwencke C, Okumura S, Yamamoto M, Geng YJ, Ishikawa Y. Colocalization of beta-adrenergic receptors and caveolin within the plasma membrane. J Cell Biochem 75: 64-72, 1999.
47. Seachrist JL, Anborgh PH, Ferguson SS. beta 2-adrenergic receptor internalization, endosomal sorting, and plasma membrane recycling are regulated by rab GTPases. J Biol Chem 275: 27221-27228, 2000.
48. Small KM, Brown KM, Forbes SL, Liggett SB. Modification of the beta 2-adrenergic receptor to engineer a receptor-effector complex for gene therapy. J Biol Chem 276: 31596-31601, 2001.
49. Soeder KJ, Snedden SK, Cao W, Della Rocca GJ, Daniel KW, Luttrell LM, Collins S. The beta3-adrenergic receptor activates mitogen-activated protein kinase in adipocytes through a Gi-dependent mechanism. J Biol Chem 274: 12017-12022, 1999.
50. Su X, Kong C, Stahl PD. GAPex-5 mediates ubiquitination, trafficking, and degradation of epidermal growth factor receptor. J Biol Chem 282: 21278-21284, 2007.
51. Su X, Lodhi IJ, Saltiel AR, Stahl PD. Insulin-stimulated Interaction between insulin receptor substrate 1 and p85alpha and activation of protein kinase B/Akt require Rab5. J Biol Chem 281: 27982-27990, 2006.
52. Su X, Mancuso DJ, Bickel PE, Jenkins CM, Gross RW. Small interfering RNA knockdown of calcium-independent phospholipases A2 beta or gamma inhibits the hormone-induced differentiation of 3T3-L1 preadipocytes. J Biol Chem 279: 21740-21748, 2004.
53. Turner SM, Roy S, Sul HS, Neese RA, Murphy EJ, Samandi W, Roohk DJ, Hellerstein MK. Dissociation between adipose tissue fluxes and lipogenic gene expression in ob/ob mice. Am J Physiol Endocrinol Metab 292: E1101-E1109, 2007.
54. Uysal KT, Scheja L, Wiesbrock SM, Bonner-Weir S, Hotamisligil GS. Improved glucose and lipid metabolism in genetically obese mice lacking aP2. Endocrinology 141: 3388-3396, 2000.
55. Vaughan DJ, Millman EE, Godines V, Friedman J, Tran TM, Dai W, Knoll BJ, Clark RB, Moore RH. Role of the G protein-coupled receptor kinase site serine cluster in beta2-adrenergic receptor internalization, desensitization, and beta-arrestin translocation. J Biol Chem 281: 7684-7692, 2006.
56. Yin W, Mu J, Birnbaum MJ. Role of AMP-activated protein kinase in cyclic AMP-dependent lipolysis In 3T3-L1 adipocytes. J Biol Chem 278: 43074-43080, 2003.
57. Zhou YP, Grill VE. Long-term exposure of rat pancreatic islets to fatty acids inhibits glucose-induced insulin secretion and biosynthesis through a glucose fatty acid cycle. J Clin Invest 93: 870-876, 1994.